April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
Wall Street Lunch: Big Tech Bearishness?
Apple Should Climb The Wall Of Worry
Microsoft Q3 Preview: Focusing On Copilot
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
CRISPR Therapeutics (CRSP) stock forecast for 2024
Updated: April 23, 2024 (07:48)
Sector: HealthcareThe share price of CRISPR Therapeutics AG (CRSP) now
50/200 Day Moving Average: $72.73 / $59.49
This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the resistance level today.
For CRISPR Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in CRISPR Therapeutics AG stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the CRISPR Therapeutics stock price in 2024. How much will one CRISPR Therapeutics share be worth in 2024? Is it worth taking profit / loss on CRSP stock now or waiting? What are analysts' forecasts for CRISPR Therapeutics stock?
We forecast CRISPR Therapeutics stock performance using neural networks based on historical data on CRSP stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
CRISPR Therapeutics AG stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for CRISPR Therapeutics analysts is $85.88. Today 200 Day Moving Average is the support level (59.49 $). 50 Day Moving Average is the resistance level (72.73 $).
Historical and forecast chart of CRISPR Therapeutics AG stock
The chart below shows the historical price of CRISPR Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRSP stock price can be found in the table below.
CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.
CRISPR Therapeutics (CRSP) Forecast for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May | 59.49 | 54.16 | 63.49 | 14.69 % |
| Jun | 68.25 | 65.41 | 73.71 | 11.26 % |
| Jul | 62.90 | 55.85 | 65.21 | 14.35 % |
| Aug | 66.22 | 59.12 | 74.48 | 20.63 % |
| Sep | 55.73 | 51.00 | 59.03 | 13.60 % |
| Oct | 60.54 | 56.76 | 64.81 | 12.41 % |
| Nov | 66.74 | 63.75 | 68.98 | 7.59 % |
| Dec | 70.91 | 68.07 | 79.53 | 14.41 % |
CRISPR Therapeutics information and performance
BAARERSTRASSE 14, ZUG, CH
Market capitalization of the CRISPR Therapeutics AG is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRSP shares in the company outstanding by the market price of one share.
EBITDA of CRISPR Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
CRISPR Therapeutics price target for 2024 by month
Target values for the price of one CRISPR Therapeutics share for May 2024.
In May, the Positive dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 14.693% volatility is expected.
Pessimistic target level: 54.16
Optimistic target level: 63.49
Target values for the price of one CRISPR Therapeutics share for Jun 2024.
In Jun, the Positive dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 11.259% volatility is expected.
Pessimistic target level: 65.41
Optimistic target level: 73.71
Target values for the price of one CRISPR Therapeutics share for Jul 2024.
In Jul, the Negative dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 14.352% volatility is expected.
Pessimistic target level: 55.85
Optimistic target level: 65.21
Target values for the price of one CRISPR Therapeutics share for Aug 2024.
In Aug, the Positive dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 20.626% volatility is expected.
Pessimistic target level: 59.12
Optimistic target level: 74.48
Target values for the price of one CRISPR Therapeutics share for Sep 2024.
In Sep, the Negative dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 13.595% volatility is expected.
Pessimistic target level: 51.00
Optimistic target level: 59.03
Target values for the price of one CRISPR Therapeutics share for Oct 2024.
In Oct, the Positive dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 12.407% volatility is expected.
Pessimistic target level: 56.76
Optimistic target level: 64.81
Target values for the price of one CRISPR Therapeutics share for Nov 2024.
In Nov, the Positive dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 7.585% volatility is expected.
Pessimistic target level: 63.75
Optimistic target level: 68.98
Target values for the price of one CRISPR Therapeutics share for Dec 2024.
In Dec, the Positive dynamics for CRISPR Therapeutics AG shares will prevail with possible monthly volatility of 14.408% volatility is expected.
Pessimistic target level: 68.07
Optimistic target level: 79.53
Related stocks from Healthcare sector
